|
|
|
|
Vol. 16, Issue 7, 3260-3272, July 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Experimental and Diagnostic Medicine, Section of General Pathology, and Interdisciplinary Center for the Study of Inflammation, University of Ferrara, 44100 Ferrara, Italy
Submitted November 23, 2004;
Revised May 4, 2005;
Accepted May 6, 2005
Monitoring Editor: Guido Guidotti
P2X7 is a bifunctional receptor (P2X7R) for extracellular ATP that, depending on the level of activation, forms a cation-selective channel or a large conductance nonselective pore. The P2X7R has a strong proapoptotic activity but can also support growth. Here, we describe the mechanism involved in growth stimulation. Transfection of P2X7R increases resting mitochondrial potential (
mt), basal mitochondrial Ca2+ ([Ca2+]mt), intracellular ATP content, and confers ability to grow in the absence of serum. These changes require a full pore-forming function, because they are abolished in cells transfected with a mutated P2X7R that retains channel activity but cannot form the nonselective pore, and depend on an autocrine/paracrine tonic stimulation by secreted ATP. On the other hand, sustained stimulation of P2X7R causes a 
mt drop, a large increase in [Ca2+]mt, mitochondrial fragmentation, and cell death. These findings reveal a hitherto undescribed mechanism for growth stimulation by a plasma membrane pore.
Abbreviations used: BzATP, benzoyl ATP; [Ca2+]i, cytosolic Ca2+ concentration; [Ca2+]mt, mitochondrial Ca2+ concentration; 
mt, mitochondrial potential; ER, endoplasmic reticulum; FCCP, carbonyl cyanide a-[3-(2-benzothiazolyl)6-[2-[2-[bis(carboxymethyl)amino]-5-methylphenoxy]-2-oxo-2H-1-benzopyran-7yl]-b-(carboxymethyl)-tetrapotassium salt; mtAEQ, mitochondrial aequorin; mt-GFP, mitochondrial green fluorescent protein; oATP, oxidized ATP; P2X7R, P2X7 receptor; P2X7
CR, truncated P2X7 receptor; TMRM, tetramethylrhodamine methyl ester.
Address correspondence to: Francesco Di Virgilio (fdv{at}unife.it).
This article has been cited by other articles:
![]() |
S. Roger, P. Pelegrin, and A. Surprenant Facilitation of P2X7 Receptor Currents and Membrane Blebbing via Constitutive and Dynamic Calmodulin Binding J. Neurosci., June 18, 2008; 28(25): 6393 - 6401. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Panupinthu, J. T. Rogers, L. Zhao, L. P. Solano-Flores, F. Possmayer, S. M. Sims, and S. J. Dixon P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis J. Cell Biol., May 28, 2008; 181(5): 859 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Solini, S. Cuccato, D. Ferrari, E. Santini, S. Gulinelli, M. G. Callegari, A. Dardano, P. Faviana, S. Madec, F. Di Virgilio, et al. Increased P2X7 Receptor Expression and Function in Thyroid Papillary Cancer: A New Potential Marker of the Disease? Endocrinology, January 1, 2008; 149(1): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baroni, C. Pizzirani, M. Pinotti, D. Ferrari, E. Adinolfi, S. Calzavarini, P. Caruso, F. Bernardi, and F. Di Virgilio Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles FASEB J, June 1, 2007; 21(8): 1926 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lemaire, S. Falzoni, N. Leduc, B. Zhang, P. Pellegatti, E. Adinolfi, P. Chiozzi, and F. Di Virgilio Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells J. Immunol., November 15, 2006; 177(10): 7257 - 7265. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Raffaghello, P. Chiozzi, S. Falzoni, F. Di Virgilio, and V. Pistoia The P2X7 Receptor Sustains the Growth of Human Neuroblastoma Cells through a Substance P-Dependent Mechanism Cancer Res., January 15, 2006; 66(2): 907 - 914. [Abstract] [Full Text] [PDF] |
||||